Poppy processor Palla Pharma has agreed to pay $1.125 million to rival Tasmanian Alkaloids t0 settle a lawsuit alleging infringement of two innovation patents for high codeine-concentrated poppy.
The Australian Competition and Consumer Commission is appealing the dismissal of its case over Pactific National’s purchase of Aurizon’s Acacia Ridge Terminal in Queensland, challenging the Federal Court’s power to accept Pacific National’s last-minute promise to ensure access to the major freight terminal by competitors.
AMP is a facing a second class action for allegedly charging excessive fees on more than two million superannuation accounts, setting up another potential class action beauty pageant.
We have been told for so long that the volume of class action litigation continues to increase at a rapid rate, thus requiring significant legislative intervention, that the title of this piece may (legitimately) prompt at least some readers to check if today is the 1st of April. But this is no April Fools’ Day prank.
Facing cross claims by Pitcher Partners in two shareholder class actions alleging the accounting firm wrongly signed off on Slater & Gordon’s financial reports ahead of a share price nosedive, the law firm and its ex-directors say they relied on the auditor to ensure the veracity of the statements.
Domino’s Pizza says it will defend a class action filed against it on behalf of thousands of delivery drivers and in-store workers who were allegedly systemically underpaid by franchisees over a five-year period.
Dairy supplier Murray Goulburn has agreed to pay $42 million to settle one of two shareholder class actions over a 2016 profit forecast revision that sent the co-op’s unit price falling more than 40 per cent in five days.
Three shareholder class actions against RCR Tomlinson have been allowed to continued, setting up a class action beauty contest over who will lead the litigation against the failed engineering company.
Global pharmaceutical giant Pfizer has successfully defended the patent for its sedative drug Precedex against a validity challenge, a big win for the drug maker after a US court found last year that its patents for a ready-to-use version of the drug were invalid for obviousness.
Rival law firms Phi Finney McDonald and Maurice Blackburn have offered to consolidate their competing shareholder class actions against BHP after prompting by the Full Federal Court, which said Friday it approved of the plan.